🇺🇸 FDA
Pipeline program

IPN10200 placebo, Powder for solution for injection, DYSPORT 500 UNITES SPEYWOOD, poudre pour solution injectable

D-FR-10200-001

Phase 2 small_molecule active

Quick answer

IPN10200 placebo, Powder for solution for injection, DYSPORT 500 UNITES SPEYWOOD, poudre pour solution injectable for Upper limb spasticity after stroke or traumatic brain injury is a Phase 2 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Ipsen Pharma
Indication
Upper limb spasticity after stroke or traumatic brain injury
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials